Expert: How Social Media Impacts the Mental Health of Health Care Professionals
October 27th 2021Paula Durlofsky, PhD, a writer for the American Psychological Association's Device Management and Digital Intelligence committee discusses how social media has impacted the mental health of health care professionals in recent years, including the COVID-19 Pandemic.
Overview of Burkitt Lymphoma, the Patient Populations Most Impacted
October 25th 2021Adam Olszewski, MD, associate professor of medicine in Alpert Medical School at Brown University, discusses his SOHO 2021 conference presentation on prognostication and treatment of Burkitt lymphoma in the modern era.
This World Standards Week, USP Sheds Light on Key Shifts in Standards Development
October 25th 2021World Standards Week is October 25 to 29, so Pharmacy Times interviewed Jaap Venema, PhD, EVP and CSO at USP, on some of the key shifts that have occurred in USP’s standards development during the COVID-19 pandemic.
Current Treatments, Drug Pipeline, Initial Management in Oncologic Emergencies
October 21st 2021Jameshia Below, PharmD, an assistant professor of pharmacy practice at the University of Louisiana Monroe College of Pharmacy, explains the initial management process for oncologic emergencies, the treatments currently available, and treatments coming in the drug pipeline.
How the National Blood Shortage May Impact Patient Care, Outcomes
October 21st 2021Jennifer Andrews, MD, pediatric hematologist-oncologist at Vanderbilt University Medical Center and medical director of Vanderbilt University Medical Center’s blood bank, discusses how a national blood shortage could affect patient care and outcomes.
Potential Drug-Drug Interactions With Psilocybin, MDMA, Ketamine
October 21st 2021Kelan Thomas, PharmD, MS, associate professor of clinical sciences at Touro University California College of Pharmacy, discusses potential drug-drug interactions with psilocybin, MDMA, and ketamine to consider outside of interactions with psychiatric medications.
Stand Up To Cancer, Jazz Pharmaceuticals Collaborate to Accelerate Drug Development
October 20th 2021In an interview with Pharmacy Times®, Lee Helman, MD, vice chair on Stand Up To Cancer's Scientific Advisory Committee, discusses the research collaboration between Stand Up To Cancer and Jazz Pharmaceuticals.
Social Media Campaign Aims to Raise Awareness, Create Change for Pharmacy Working Conditions
October 19th 2021The #PizzaIsNotWorking campaign originated because free pizza or other mundane incentives do not adequately address the unrealistic expectations in pharmacies, which lead to an emphasis on metrics rather than patient safety.
Expert: MDMA for the Treatment of PTSD May Be FDA-Approved by the End of 2023
October 19th 2021Ismail Lourido Ali, the director and counsel of policy and advocacy at the Multidisciplinary Association for Psychedelic Studies (MAPS), discusses what MAPS is, and how MAPS is engaged with the field of psychedelic medicine and its use in health care.
New Drugs and Clinical Pearls in the Community Setting
October 18th 2021Pezzino discussed new specific prescriptions and treatments compared to current treatment modalities, indications and routes of administration of new drugs in the community setting, and important pharmacokinetic properties of these new drugs.